Indeed, a recent umbrella review demonstrated with moderate evidence certainty that CGM improves glycemic outcomes in T2DM (HbA1c mean difference with CGM, 0.40% [95% CI, 0.54 to 0.25]), irrespective of age and insulin-use status [88]
Journal of Endocrinology and Metabolism, 3(12), 715.
Therefore, there is no difference between injecting in the abdomen versus over the area of pain when we talk about how the peptide gets to the damaged tissue
Pernicious anemia is a condition in which the body cannot adequately absorb vitamin B12
Most clinicians recommend restarting at 2.5 mg once weekly after a month-long break to minimise gastrointestinal side effects, even if you previously tolerated higher doses
Youll feel the difference as early as 30 minutes